M-A: Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia.

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link to abstract – $ for full-text)

Commentary: Long-acting injectable antipsychotics: more effective than oral medications at preventing hospitalisation and relapse in schizophrenia according to new review – The Mental Elf

Commentary on Twitter

"Taken together, the results suggest increased use of long-acting injectable antipsychotics in clinical practice should be considered."

New Researchhttps://t.co/l2Ow9BzCUu

— The Lancet Psychiatry (@TheLancetPsych) April 14, 2021